Could the anti-cancer gene p53 be a target in treating kidney cancer?

Scientists at Sidney Kimmel Cancer Center – Jefferson Health discovered a link between one of the most commonly mutated genes in kidney cancer, PBRM1, and the cancer-suppressing gene p53. The findings could inspire treatments that might be able to activate p53 in kidney cancer patients with PBRM1 mutations.

Read the full article here

Related Articles